Screener
AngioDynamics ANGO Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by AngioDynamics in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The source filing: AngioDynamics’s 10-K, filed July 14, 2026.
- Filed
- Jul 14, 2026, 3:42 PM EDT
- Fiscal year
- FY2026
- Accession
- 0001628280-26-048138
| Line item | May 31, 2026 | May 31, 2025 |
|---|---|---|
| Total Assets | $267,163 | $280,144 |
| Liabilities and Stockholders' Equity | ||
| Current Liabilities | ||
| Accounts payable | $31,513 | $33,291 |
| Accrued liabilities | 38,909 | 35,518 |
| Other current liabilities | 4,295 | 7,388 |
| Total current liabilities | 74,717 | 76,197 |
| Deferred income taxes | 5,316 | 4,073 |
Item 15. Exhibits, Financial Statement Schedules.
FAQ
- What is AngioDynamics's accounts payable?
- AngioDynamics (ANGO) reported accounts payable of $31.51M in Q1 2026.
- How has AngioDynamics's accounts payable changed year-over-year?
- AngioDynamics's accounts payable decreased by 5.3% year-over-year, from $33.29M to $31.51M.
- What is the long-term trend for AngioDynamics's accounts payable?
- Over 5 years (2021 to 2026), AngioDynamics's accounts payable has grown at a 9.9% compound annual growth rate (CAGR), from $19.63M to $31.51M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.
Ask your AI about AngioDynamics's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude